Tau phosphorylation: the therapeutic challenge for neurodegenerative disease
- 31 March 2009
- journal article
- review article
- Published by Elsevier BV in Trends in Molecular Medicine
- Vol. 15 (3), 112-119
- https://doi.org/10.1016/j.molmed.2009.01.003
Abstract
No abstract availableKeywords
This publication has 72 references indexed in Scilit:
- Amyloid Activates GSK-3β to Aggravate Neuronal Tauopathy in Bigenic MiceThe American Journal of Pathology, 2008
- Transcriptional Regulation of β-Secretase by p25/cdk5 Leads to Enhanced Amyloidogenic ProcessingNeuron, 2008
- Lithium Reduces Tau Phosphorylation but Not Aβ or Working Memory Deficits in a Transgenic Model with Both Plaques and TanglesThe American Journal of Pathology, 2007
- Pin1 in Alzheimer's disease: Multiple substrates, one regulatory mechanism?Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2007
- Accumulation of Pathological Tau Species and Memory Loss in a Conditional Model of TauopathyJournal of Neuroscience, 2007
- Regulation of Alzheimer's disease amyloid-β formation by casein kinase IProceedings of the National Academy of Sciences of the United States of America, 2007
- An inhibitor of tau hyperphosphorylation prevents severe motor impairments in tau transgenic miceProceedings of the National Academy of Sciences of the United States of America, 2006
- Tau Suppression in a Neurodegenerative Mouse Model Improves Memory FunctionScience, 2005
- Mechanism of Phosphorylation-Dependent Binding of APC to β-Catenin and Its Role in β-Catenin DegradationMolecular Cell, 2004
- Reactivating Kinase/p38 Phosphorylates τ Protein In VitroJournal of Neurochemistry, 1997